Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 472750, 9 pages
http://dx.doi.org/10.1155/2015/472750
Research Article

Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients

1Departamento de Analises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, 31270901 Belo Horizonte, MG, Brazil
2Departamento de Ciências da Saúde, Faculdade de Farmácia, Universidade Federal de São João del-Rei, 35501296 Divinópolis, MG, Brazil
3Departamento de Pediatria, Faculdade de Medicina, Universidade Federal de Minas Gerais, 30130100 Belo Horizonte, MG, Brazil

Received 24 March 2015; Revised 30 May 2015; Accepted 16 June 2015

Academic Editor: Shih-Ping Hsu

Copyright © 2015 Ana Paula Lucas Mota et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Galliford and D. S. Game, “Modern renal transplantation: present challenges and future prospects,” Postgraduate Medical Journal, vol. 85, no. 1000, pp. 91–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Ponticelli, “The mechanisms of acute transplant rejection revisited,” Journal of Nephrology, vol. 25, no. 2, pp. 150–158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Fourtounas, “Transplant options for patients with type 2 diabetes and chronic kidney disease,” World Journal of Transplantation, vol. 4, no. 2, pp. 102–110, 2014, (Abstract). View at Google Scholar
  4. Y. Zeng, Z. Liu, Y. Liu, Y. Fan, Y. Guo, and J. Qiu, “Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts,” Urologia Internationalis, vol. 92, no. 3, pp. 328–333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Lezaic, D. Mirkovic, S. Ristic et al., “Potential influence of tubular dysfunction on the difference between estimated and measured glomerular filtration rate after kidney transplantation,” Transplantation Proceedings, vol. 45, no. 4, pp. 1651–1654, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. O. El-Minshawy and E. El-Bassuoni, “Validity of current equations to estimate glomerular filtration rate in kidney transplant recipients,” Transplantation Proceedings, vol. 45, no. 6, pp. 2165–2170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-S. Park, I. H. Oh, C. H. Lee, G.-H. Kim, and C. M. Kang, “The rate of decline of glomerular filtration rate is a predictor of long-term graft outcome after kidney transplantation,” Transplantation Proceedings, vol. 45, no. 4, pp. 1438–1441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Levitsky, A. Freifeld, E. Lyden et al., “Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors,” Clinical Transplantation, vol. 23, no. 6, pp. 943–950, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. P. L. Mota, S. S. Vilaça, F. L. das Mercês et al., “Cytokines signatures in short and long-term stable renal transplanted patients,” Cytokine, vol. 62, no. 2, pp. 302–309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Adams, A. B. Irish, G. F. Watts, R. Oostryck, and G. K. Dogra, “Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function,” Thrombosis Research, vol. 123, no. 2, pp. 374–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Malyszko, J. S. Malyszko, T. Hryszko, and M. Mysliwiec, “Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients,” Transplantation Proceedings, vol. 38, no. 1, pp. 105–107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Guo-Yuan, L. Shen, Z.-Y. Wang et al., “Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases,” Chinese Medical Journal, vol. 121, no. 2, pp. 133–136, 2008. View at Google Scholar · View at Scopus
  13. M. Manea, R. Tati, J. Karlsson, Z. D. Békássy, and D. Karpman, “Biologically active ADAMTS13 is expressed in renal tubular epithelial cells,” Pediatric Nephrology, vol. 25, no. 1, pp. 87–96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Ministério da Saúde, Portaria 666 de 17 de julho de 2012. Protocolo clínico e diretrizes terapêuticas—immunossupressão no transplante renal, Secretário de Atenção à Saúde, 2012.
  15. K. L. Womer and B. Kaplan, “Recent developments in kidney transplantation—a critical assessment,” The American Journal of Transplantation, vol. 9, no. 6, pp. 1265–1271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Kozakowski and H. Regele, “Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function,” Transplant International, vol. 22, no. 10, pp. 945–953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. R. Rios, A. P. L. Mota, M. G. Carvalho et al., “ADAMTS13 and von Willebrand factor assessment before and after kidney transplantation,” Clinica Chimica Acta, vol. 412, no. 23-24, pp. 2353–2354, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. R. A. Rios, M. G. Carvalho, R. C. Figueiredo et al., “ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis,” Journal of Thrombosis and Thrombolysis, vol. 34, no. 1, pp. 73–78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Humar, T. Ramacharan, R. Kandaswamy, K. Gillingham, W. D. Payne, and A. J. Matas, “Risk factors for slow graft function after kidney transplants: a multivariate analysis,” Clinical Transplantation, vol. 16, no. 6, pp. 425–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Hryszko, J. Malyszko, J. S. Malyszko, S. Brzosko, K. Pawlak, and M. Mysliwiec, “A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients,” Nephrology Dialysis Transplantation, vol. 16, no. 8, pp. 1692–1696, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Pawlicki, L. Cierpka, R. Król, and J. Ziaja, “Analysis of coagulation parameters in the early period after kidney transplantation,” Transplantation Proceedings, vol. 39, no. 9, pp. 2754–2755, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Pawlicki, L. Cierpka, R. Król, and J. Ziaja, “Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation,” Transplantation Proceedings, vol. 43, no. 8, pp. 3013–3017, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Ballow, A. M. Gader, S. Huraib, A. Mitwalli, F. Al-Suleimani, and J. Al-Wakeel, “Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis,” Saudi Journal of Kidney Diseases and Transplantation, vol. 18, no. 2, pp. 177–185, 2007. View at Google Scholar · View at Scopus
  24. T. Akiyama, M. Ikegami, T. Uemura et al., “Urinary tissue-type plasminogen activator (tPA) in renal transplant patients,” Nihon Hinyokika Gakkai Zasshi, vol. 82, no. 4, pp. 565–571, 1991, (abstract). View at Google Scholar
  25. R. Dubin, M. Cushman, A. R. Folsom et al., “Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis,” BMC Nephrology, vol. 12, article 3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Fiorina, F. Folli, F. Bertuzzi et al., “Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney transplanted patients,” Diabetes Care, vol. 26, no. 4, pp. 1129–1136, 2003. View at Publisher · View at Google Scholar
  27. T. Rampino, M. Marasà, P. M. Malvezzi et al., “Platelet-independent defect in hemostasis associated with sirolimus use,” Transplantation Proceedings, vol. 36, no. 3, pp. 700–702, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. S. Adam, N. S. Key, and C. S. Greenberg, “D-dimer antigen: current concepts and future prospects,” Blood, vol. 113, no. 13, pp. 2878–2887, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. R. G. Giribela, R. Gengo, V. Hong, and F. M. Consolim-Colombo, “Função e disfunção endotelial: da fisiopatologia às perspectivas de uso em pesquisa e na prática clínica,” Revista Brasileira de Hipertensão, vol. 18, no. 1, pp. 27–32, 2011. View at Google Scholar
  30. J. S. Małyszko, J. Małyszko, T. Hryszko, P. Koźminski, K. Pawlak, and M. Mysliwiec, “Markers of endothelial damage in patients on hemodialysis and hemodiafiltration,” Journal of Nephrology, vol. 19, no. 2, pp. 150–154, 2006. View at Google Scholar · View at Scopus
  31. J. Malyszko, J. S. Malyszko, K. Pawlak, and M. Mysliwiec, “Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients,” Transplantation Proceedings, vol. 40, no. 10, pp. 3470–3473, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Kavanagh and T. Goodship, “Genetics and complement in atypical HUS,” Pediatric Nephrology, vol. 25, no. 12, pp. 2431–2442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Zbroch, J. Małyszko, J. Małyszko, E. Koc-Żórawska, and M. Myśliwiec, “Renalase, kidney function, and markers of endothelial dysfunction in renal transplant recipients,” Polskie Archiwum Medycyny Wewnetrznej, vol. 122, no. 1-2, pp. 40–44, 2012. View at Google Scholar · View at Scopus
  34. K.-L. Liu, K.-T. Lee, C.-H. Chang, Y.-C. Chen, S.-M. Lin, and P.-H. Chu, “Elevated plasma thrombomodulin and angiopoietin-2 predict the development of acute kidney injury in patients with acute myocardial infarction,” Critical Care, vol. 18, no. 3, article R100, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y.-H. Li, C.-H. Kuo, G.-Y. Shi, and H.-L. Wu, “The role of thrombomodulin lectin-like domain in inflammation,” Journal of Biomedical Science, vol. 19, article 34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Seki, K. Toba, I. Fuse et al., “In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells,” Thrombosis Research, vol. 115, no. 3, pp. 219–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Takahashi, H. Wada, M. Usui et al., “Behavior of ADAMTS13 and von Willebrand factor levels in patients after living donor liver transplantation,” Thrombosis Research, vol. 131, no. 3, pp. 225–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. G.-Y. Lu, L. Shen, Z.-Y. Wang et al., “Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases,” Chinese Medical Journal, vol. 121, no. 2, pp. 133–136, 2008. View at Google Scholar · View at Scopus
  39. X. L. Zheng, D. Chung, T. K. Takayama, E. M. Majerus, J. E. Sadler, and K. Fujikawa, “Structure of von willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura,” The Journal of Biological Chemistry, vol. 276, no. 44, pp. 41059–41063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. C. A. Burtis, E. R. Ashwood, and D. E. Bruns, Tietz-Fundamentos de Química Clínica, Elsevier, Rio de Janeiro, Brasil, 2008.
  41. Y. J. Jung, H. R. Lee, and O. J. Kwon, “Comparison of serum cystatin C and creatinine as a marker for early detection of decreasing glomerular filtration rate in renal transplants,” Journal of the Korean Surgical Society, vol. 83, no. 2, pp. 69–74, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. A. B. Pereira, A. L. Teixeira, N. A. Rezende et al., “Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study,” International Urology and Nephrology, vol. 44, no. 5, pp. 1539–1548, 2012. View at Publisher · View at Google Scholar · View at Scopus